Search company, investor...

Stage

Grant | Dead

Total Raised

$6.4M

Last Raised

$2.7M

About Elara Pharmaceuticals

Elara Pharmaceuticals is a Heidelberg, Germany-based biotech company focused on the development of drugs for the treatment of different cancers.

Headquarters Location

Germany

Loading...

Loading...

Elara Pharmaceuticals Frequently Asked Questions (FAQ)

  • What is Elara Pharmaceuticals's latest funding round?

    Elara Pharmaceuticals's latest funding round is Grant.

  • How much did Elara Pharmaceuticals raise?

    Elara Pharmaceuticals raised a total of $6.4M.

  • Who are the investors of Elara Pharmaceuticals?

    Investors of Elara Pharmaceuticals include BMBF GOBio, BioRN - Biotechnologie Rhein-Neckar, KfW, EMBL Ventures and Wagnisfinanzierungsgesellschaft fuer Technologiefoerderung in Rheinland-Pfalz.

  • Who are Elara Pharmaceuticals's competitors?

    Competitors of Elara Pharmaceuticals include Kythera Biopharmaceuticals, Idenix Pharmaceuticals, ugichem, Callisto Pharmaceuticals, Excaliard Pharmaceuticals and 7 more.

Loading...

Compare Elara Pharmaceuticals to Competitors

I
Inflazyme Pharmaceuticals

Inflazyme Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and inflammatory diseases. The company's core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.

Longevica Logo
Longevica

Longevica is a biotechnology that is researching mechanisms of healthy aging and life extension. The company is also developing an open research tool for scientists and research institutions to access a data set that tracks the effects of pharmacological compounds for testing drugs.

A
Affibody

Affibody is a private clinical-stage biotech company. It specializes in the discovery of antibody mimetics that provide biodistribution flexibility, tissue penetration, and tumor targeting. The company was founded in 1998 and is based in Solna, Sweden.

S
Sound Pharmaceuticals

Sound Pharmaceuticals (SPI) is a biopharmaceutical company that develops prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans. It was founded in 2002 and is based in Seattle, Washington.

B
Bikam Pharmaceuticals

BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, there are approximately 1.5 million people which suffer from retinitis pigmentosa (RP), a hereditary disease which leads to blindness. As its initial priority, the company is pursuing the discovery of compounds based on a novel mechanism of action identified by the company's founder, Dr. Shalesh Kaushal. BIKAM has an experienced management team with a strong track record in pharmaceutical drug discovery dedicated to expanding these findings and others from the Kaushal lab to create potential therapeutics to prevent blindness.

G
Greenovation Biotech

greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.